- Home
- NUS vs CCIX Comparison
NUS vs CCIX Comparison
Compare NUS & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUS | CCIX |
|---|---|---|
| Founded | 1984 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.0M | 391.9M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NUS | CCIX |
|---|---|---|
| Price | $7.13 | $10.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 459.3K | 12.2K |
| Earning Date | 05-07-2026 | 11-07-2013 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ 207.80 | N/A |
| EPS | ★ 3.18 | N/A |
| Revenue | ★ $3,176,718,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | ★ $2.28 | $45.59 |
| Revenue Growth | ★ 48.98 | N/A |
| 52 Week Low | $5.32 | $10.46 |
| 52 Week High | $14.62 | $11.66 |
Technical Indicators
Market Signals| Indicator | NUS | CCIX |
|---|---|---|
| Relative Strength Index (RSI) | 29.36 | 55.88 |
| Support Level | $7.05 | $10.55 |
| Resistance Level | $10.90 | $10.71 |
| Average True Range (ATR) | 0.21 | 0.02 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 19.67 | 71.43 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.